ArticleiScience2026
A cell comparative multiple instance learning network guided by image quality assessment for cervical whole slide image classification.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early screening is essential for reducing the incidence and mortality of cervical cancer, and artificial intelligence-based analysis of whole slide images (WSIs) enables large-scale automated screening. However, existing methods often ignore image quality variations and inter-individual morphological differences, which limits their robustness in clinical settings. This study proposes a quality-aware cervical WSI classification framework that integrates image quality assessment with pathologist-inspired normal-abnormal cell comparison. A quality evaluation module filters unreliable patches, while a cell comparison and enhancement strategy enlarges the feature discrepancy between normal and abnormal cells to mitigate individual variability. Supervised contrastive learning further strengthens abnormal cell discrimination, and patch-level quality scores are incorporated into an attention-based multiple instance learning framework to guide WSI classification. Experiments on 2,434 WSIs from five medical institutions demonstrate that our method achieves superior performance in real-world scenarios, significantly outperforming state-of-the-art methods by 1.93% in average overall accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.